Valeria C. Cohran, MD, from Ann & Robert H. Lurie Children’s Hospital of Chicago, discusses the current state of pediatric intestinal rehabilitation programs, treatment advances led by these programs, and more.

Joseph Diamond, MD, from the Icahn School of Medicine, answers the question at the end of Case #3 and discusses the difference between at-home vs in-lab polysomnography testing for sleep disordered breathing. Case part 3 here:

In part 2 of our series on lipid management, Dr Paul Jellinger explains the answer to the quiz question from part 1, the AACE lipid guidelines, and the role of renal disease in managing this patient. Part 1 here: https://www.consultant360.com/exclusive/cardiology/lipid-metabolic/what-older-mans-ldl-c-goal.

Jacob Miguel Vigil, PhD, discusses new study findings that suggest THC may confer more therapeutic benefit than CBD across many different health conditions, and why he says now is the “Golden Age” of cannabis research. For more, visit www.consultant360.com.

James Matera, DO, from CentraState Medical Center in New Jersey, discusses how lipid disorders impact the management of chronic kidney disease (CKD), and whether statins are safe for use in patients with comorbid lipid disorders and CKD. For more, visit www.consultant360.com.

David Malebranche, MD, MPH, talks about his session from the 2019 National HIV Prevention Conference, titled "We Are Family: Helping Patients Navigate the HIV Care Continuum." He discusses the current HIV care continuum, the knowledge gaps that still exist, and the art and science of medicine in HIV care. Read more: https://www.consultant360.com/specialty/infectious-diseases/hivaids.

Deepak Kaushal, PhD, from Texas Biomedical Research Institute, talks about new treatments for HIV, how they will change the way we treat HIV, and other medications for HIV on the horizon. More athttps://www.consultant360.com/specialty/infectious-diseases/hivaids.

Michael Reid, MD, from University of California, San Francisco, discusses the newest HIV-TB prevention therapies, the latest research on a new tuberculosis vaccine, and more.

Michael V. Chiorean, MD, provides insight on how gastroenterologists can prevent and manage their patients with colitis caused by Clostridium difficile, a topic he will discuss at the Advances in Inflammatory Bowel Disease Regional Meeting in Los Angeles, California.

Antje Bischof, from the University of California, San Fransisco, talks about her research "Accelerated Cord Atrophy Precedes Conversion to Secondary Progressive Disease in Relapsing Multiple Sclerosis," which she presented at ACTRIMS Forum 2019. Read more at